Medical Record Review Challenges in MDL Litigation

Medical record review wins or loses mass tort cases long before a bellwether is picked, and in an MDL the review is happening across thousands of claimants at once. Feeling like the record volume in your MDL has outgrown the way your team reviews it? You are not alone, and the fix starts with seeing why MDL review is a different animal.

Let's start with what actually changes. A medical record review reads, organizes, and cross-references a claimant's documented care so the legal team can find what matters fast. In a single case, that is one set of records and one story. In an MDL, it is the same review standard repeated across a claimant inventory that can run to thousands of people and millions of pages. The task does not just get bigger. It changes shape.

Why is MDL record review different from a single case?

MDL record review is different because the hard part shifts from depth to consistency at scale. In one case, you go deep on one plaintiff. In an MDL, you have to hold the exact same standard across every claimant, so that a document type is classified the same way, a prior condition is flagged the same way, and a summary reads the same way whether it is claimant 12 or claimant 12,000. The moment the standard drifts between sets, the inventory stops being comparable, and comparability is what MDL work runs on.

Challenge 1: The sheer volume, and what it does to error rates

The first challenge is raw scale, and its real danger is what it does to small mistakes. An error rate that feels harmless in a single case does not stay harmless across an inventory. One misfiled or misclassified record in 40,000 pages is invisible until someone needs that exact record. Multiply that by thousands of claimant sets and a small percentage becomes hundreds of records sitting in the wrong place. Volume does not create new kinds of errors. It hides ordinary ones until the number of them starts to matter.

Challenge 2: Keeping the review consistent across every claimant

The second challenge is standardization, and it is the one that quietly decides whether an inventory holds up. When different reviewers, or the same reviewer on a tired afternoon, classify the same record type three different ways across claimants, the sets no longer line up. A defense team comparing plaintiffs will find the seam, and inconsistency in the record work becomes a way to question the record work itself. This is why judging the accuracy of a medical record index in a pharma MDL means checking consistency across claimants, not just completeness within one file.

Consistency is built, not hoped for. It comes from a fixed classification scheme, a shared template for how summaries read, and a quality check that spot-checks across claimant sets rather than inside a single tidy one. The errors that hurt an MDL hide between sets, so that is where the checking has to happen.

Challenge 3: Duplicates and disorganized productions

The third challenge arrives with the records themselves. Productions in an MDL are rarely clean. Providers re-send whole charts, the same records show up under more than one plaintiff, and pages arrive out of order and out of sequence. Merge all of that without a method and you inflate the page count a scope was quoted on, bury duplicates, and put the same record in two places under two identifiers. Before the review even starts, the pile has to be de-duplicated, placed in order, and indexed, which is why accurate chart reviews in mass tort cases depend on disciplined sorting first.

Challenge 4: Court-ordered deadlines you do not control

The fourth challenge is time, and in an MDL the clock is set by the court. Plaintiff fact sheets have filing deadlines, case management orders set the pace, census orders demand a count and a status for every claimant, and a Lone Pine order can require record-backed proof of exposure and injury for each plaintiff or risk dismissal. Each of these leans on record review, and each arrives with a date attached. When a single deadline covers thousands of claimants, the review cannot be a bottleneck, and it cannot cut corners to hit the date either.

This is where turnaround and accuracy stop being separate goals. A review that is fast but inconsistent creates work later; a review that is careful but slow misses the order. Meeting both across a full inventory is the real test, and it is why many firms hand the volume to a dedicated partner rather than absorb it in-house, a decision that also depends on clear communication when outsourcing at mass tort scale.

Challenge 5: Finding the case-defining facts across the inventory

The fifth challenge is finding the few facts that decide direction, buried in an ocean of routine pages. In mass tort work, those are usually documented exposure and product use, the timeline of onset, prior conditions, and any alternative documented cause already sitting in the chart. Surfacing and flagging these for every claimant is what lets attorneys and their retained experts weigh cases, screen the inventory, and prepare bellwether candidates. The review's job is to organize and flag what the records document and cite the page. It does not decide what caused an injury, whether a plaintiff qualifies, or who is liable. Those determinations belong to the attorneys and the retained medical experts, and a good review makes their job faster by putting the documented facts in front of them, traceable to the source.

Challenge 6: Keeping every entry defensible and traceable

The sixth challenge is defensibility, because at MDL scale the review will be tested. Bellwether discovery, expert reliance, and Daubert scrutiny all put pressure on the underlying record work, and a summary or index entry that cannot be tied back to a Bates-stamped source page is one that cannot be defended. The discipline is traceability: continuous and unique pagination, Bates numbers that resolve, and every material statement pointing to a real page. Done right, any entry in any claimant set can be checked in seconds, which is exactly what you want when the other side is looking for a seam.

Where AI fits in MDL record review, and where it does not

AI is part of what makes MDL-scale review possible now. It can index long productions, surface likely duplicates, and locate candidate records across a large inventory faster than a person working alone, which is a real help when the volume is enormous. What AI cannot reliably do on its own is read context, catch the record that contradicts the tidy story, or hold the judgment that keeps classification consistent across thousands of sets. That is why a dependable MDL review pairs AI throughput with trained medical reviewers who check the output against the source, rather than trusting automation to run unwatched across the inventory.

One boundary is worth stating plainly. A medical record review organizes, cross-references, and flags what the records document, and it cites the source. It does not diagnose, decide causation, determine which plaintiffs qualify, or assign liability. Those are calls for the attorneys and the retained experts. The review makes sure the documented evidence for every claimant is complete, consistent, and traceable, so the professionals can build on it.

Medical record review in an MDL is a scale-and-consistency problem before it is anything else. The volume magnifies small errors, the standard has to hold across every claimant, the productions arrive messy, the deadlines belong to the court, the case-defining facts hide in routine pages, and every entry has to trace back to a source. Handle those six well and the review stops being a liability and becomes the foundation the rest of the matter stands on.

Ready to keep your MDL record review consistent, on schedule, and defensible across the whole inventory? Partner with LezDo TechMed, or start with a free trial and see how the process holds at scale.